Term ends Jun 28, 2032 · High confidence
20-year base term ends Jun 28, 2032
Jun 28, 2012
Jun 28, 2032
Dec 12, 2017
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 28, 2012, when application PCT/US2012/044698, the earliest non-provisional in its chain, was filed (this one was filed Mar 15, 2013) | Jun 28, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,709,491, US 9,017,731, US 9,072,680, US 9,089,496, US 9,265,737) | resolves to Jun 28, 2032, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 28, 2032 | High confidence |
This family
| Application PCT/US2012/044698 | PCT application no patent term | no patent term |
| Application 13/844,510 | Abandoned not computed | not computed |
| US 9,017,731 | In force Jun 2032 | Jun 2032 |
| US 9,839,619 | this patent Jun 2032 | Jun 2032 |
| US 9,072,680 | In force Jun 2032 | Jun 2032 |
| Application 13/844,628 | Abandoned not computed | not computed |
| Application 13/947,861 | Abandoned not computed | not computed |
| US 8,709,491 | In force Jun 2032 | Jun 2032 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 18, 2014 Reel 32237, frame 227 | Tengler, Mark; McMahen, Russell | Neos Therapeutics LP | Assignment of Assignor's Interest |
| Oct 2, 2019 Reel 50606, frame 96 | Neos Therapeutics, LP | Encina Business Credit, LLC, as Agent | Security Interest |
| Oct 7, 2019 Reel 50638, frame 952 | Neos Therapeutics, LP | Deerfield MGMT, L.P., as Collateral Agent | Security Interest |
| Feb 10, 2022 Reel 58977, frame 69 | Neos Therapeutics, LP | Avenue Venture Opportunities Fund II, L.P. | Security Interest |
| Mar 12, 2024 Reel 66725, frame 43 | Deerfield Mgmt, L.p. | Neos Therapeutics, LP | Release of Security Interest |
| Jun 14, 2024 Reel 67728, frame 327 | Avenue Venture Opportunities Fund, L.P. | Neos Therapeutics, LP | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,709,491, US 9,017,731, US 9,072,680, US 9,089,496, US 9,265,737, ends no earlier than this term, so it caps nothing.